Beverley Hunt, M.D., OBE, Prof. dr. Saskia Middeldorp, and Jeffrey I. Weitz, M.D., F.R.C.P(C)., F.A.C.P., discuss newly presented evidence from the 2019 meeting regarding the use of DOACs in Non-Valvular Atrial Fibrillation (NVAF) patients who have underlying comorbidities.

Share this story, choose your platform!